MNTA Momenta Pharmaceuticals Inc.
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
- 13.83 P/E
- 14.27 P/S
- 1.99 P/B
- -1.54 EPS
- -466.87% Cash ROIC
- 21.74 Cash Ratio
- 0 / 0% Dividend
- 335,350.00 Avg. Vol.
- 50.72M Shares
- 679.2M Market Cap.
Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). The company applies its technology for the development of generic versions of complex drug products, as well as for th...
4-traders (press release) - May 9, 2013
4-traders (press release) - Apr 30, 2013
Momenta Pharma Q1 Loss Widens - NASDAQ
Daily Political - May 1, 2013
Motley Fool - Apr 29, 2013
NASDAQ - May 22, 2013
NASDAQ - May 15, 2013
Zacks.com - May 2, 2013
Law360 (subscription) - May 14, 2013
Reuters - Apr 30, 2013
Daily Markets (press release) - May 1, 2013